Skip to search formSkip to main contentSkip to account menu

Rhenium 186

Known as: RHENIUM RE-186, Re-186 
A radioisotope with an atomic number of 75 and a half life of 90 hours that emits beta particles and gamma rays and is used in cancer treatment and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Monte Carlo investigation of single cell beta dosimetry for intraperitoneal radionuclide therapy.
Single event spectra for five beta-emitting radionuclides (Lu-177, Cu-67, Re-186, Re-188, Y-90) were calculated for single cells… 
2001
2001
Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal models.
Highly Cited
2000
Highly Cited
2000
Radiosynovectomy in pigmented villonodular synovitis
Summary Background: Pigmented villonodular synovitis (PVS) is a very rare disorder characterized by a slowly progressive benign… 
2000
2000
Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy.
Radiation dose distributions are developed for balloon and wire sources of radioactivity within coronary arteries. The Monte… 
1999
1999
A strategy to reduce red marrow dose for intraperitoneal radioimmunotherapy.
The aim of this study was to determine whether shorter-lived radionuclides can reduce red marrow (RM) toxicity for i.p… 
Review
1998
Review
1998
Reactor-produced radionuclides at the University of Missouri Research Reactor.
Review
1996
Review
1996
Radioimmunotherapy of solid cancers: A review.
Depending on radionuclide characteristics, radioimmunotherapy (RIT) relies on radioactivity to destroy cells distant from… 
Highly Cited
1996
Highly Cited
1996
Radionuclide photon dose kernels for internal emitter dosimetry.
Photon point dose kernels and absorbed fractions were generated in water for the full photon emission spectrum of each… 
1996
1996
Re-188 labelled antibodies.
1993
1993
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response.
OBJECTIVES To determine the maximum tolerated dose, spectrum of toxicity, and response of persistent and recurrent ovarian… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)